Cargando…
Novel Vaccines and Drugs That Target the Surface Glycoproteins of Influenza Viruses, RSV, Parainfluenza Viruses, and SARS-CoV-2
Autores principales: | Russell, Charles J., Govorkova, Elena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229051/ https://www.ncbi.nlm.nih.gov/pubmed/35746631 http://dx.doi.org/10.3390/v14061160 |
Ejemplares similares
-
Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces
por: Marcink, Tara C., et al.
Publicado: (2020) -
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus
por: Simon, Susanne, et al.
Publicado: (2023) -
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
por: Le Nouën, Cyril, et al.
Publicado: (2022) -
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
por: Tripp, Ralph A., et al.
Publicado: (2022) -
Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020)